Freund John Gordon
- SEC CIK
- 0001296771
In the past year, 2 open-market sale filings worth $143.2K and no purchases.
Current role at each company
- SIBN SI-BONE, Inc.Directoras of Jun 8, 2026
- COLL Collegium Pharmaceutical, IncDirectoras of May 20, 2026
- STRO Sutro Biopharma, Inc.Directoras of Jun 10, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $143.2K
- 2 filings
- Net
- −$143.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Freund John Gordon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
COLL Collegium Pharmaceutical, Inc
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 (view filing) | May 18 | 2 days | Freund John GordonDirector | SSale | −20 | $34.05 | −$681 | 0.0%84.0K after | |
| May 18, 2026 (view filing) | May 15 | 3 days | Freund John GordonDirector | SSale | −4.13K | $34.54 | −$142.5K | −4.7%84.0K after | |
| Aug 12, 2025 (view filing) | Aug 8 | 4 days | Freund John GordonDirector | SSale | −11.7K | $34.36 | −$400.6K | −33.5%23.1K after | |
| Jun 11, 2025 (view filing) | Jun 9 | 2 days | Freund John GordonDirector | SSale | −6.60K | $30.62 | −$202.1K | −8.5%70.7K after |
SIBN SI-BONE, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 (view filing) | Aug 8 | 3 days | Freund John GordonDirector | SSale | −12.1K | $15.99 | −$194.0K | −11.7%91.8K after | |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | Freund John GordonDirector | SSale | −30.0K | $20.54 | −$616.2K | −22.4%103.9K after |